David Windley
Stock Analyst at Jefferies
(4.73)
# 261
Out of 4,479 analysts
77
Total ratings
71.11%
Success rate
15.4%
Average return
Main Sectors:
22 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NOTV Inotiv | Downgrades: Hold | $12 → $3.75 | $1.59 | +135.85% | 4 | May 14, 2024 | |
| MEDP Medpace Holdings | Upgrades: Buy | $340 → $450 | $407.24 | +10.50% | 3 | Apr 23, 2024 | |
| HUM Humana | Maintains: Buy | $411 → $381 | $373.49 | +2.01% | 6 | Apr 22, 2024 | |
| ELV Elevance Health | Maintains: Buy | $602 → $604 | $534.55 | +12.99% | 1 | Apr 19, 2024 | |
| ISRG Intuitive Surgical | Maintains: Hold | $365 → $375 | $436.24 | -14.04% | 1 | Apr 19, 2024 | |
| SHC Sotera Health Company | Upgrades: Buy | $15 → $16 | $11.58 | +33.85% | 3 | Mar 25, 2024 | |
| VEEV Veeva Systems | Maintains: Buy | $225 → $270 | $181.67 | +48.62% | 2 | Mar 4, 2024 | |
| CERT Certara | Maintains: Hold | $14 → $16 | $13.64 | +13.64% | 3 | Mar 1, 2024 | |
| WST West Pharmaceutical Services | Upgrades: Buy | $323 → $536 | $324.55 | +65.15% | 2 | Feb 7, 2024 | |
| FTRE Fortrea Holdings | Initiates: Buy | $44 | $23.86 | +84.41% | 1 | Jan 4, 2024 | |
| CI Cigna | Upgrades: Buy | $335 → $341 | $326.27 | +4.51% | 5 | Dec 11, 2023 | |
| UNH UnitedHealth Group | Maintains: Hold | $565 → $503 | $494.65 | +1.69% | 13 | Nov 20, 2023 | |
| STVN Stevanato Group | Downgrades: Hold | $39 → $29 | $18.73 | +54.83% | 2 | Nov 1, 2023 | |
| CNC Centene | Maintains: Buy | $82 → $81 | $65.34 | +23.97% | 4 | Oct 9, 2023 | |
| CTLT Catalent | Downgrades: Hold | $45 → $44 | $56.16 | -21.65% | 2 | Jun 14, 2023 | |
| CRL Charles River Laboratories International | Maintains: Hold | $233 → $203 | $203.24 | -0.12% | 10 | Mar 28, 2023 | |
| IQV IQVIA Holdings | Maintains: Buy | n/a | $208.49 | - | 2 | Nov 17, 2021 | |
| ICLR ICON PLC | Maintains: Buy | n/a | $316.51 | - | 5 | Sep 14, 2021 | |
| TDOC Teladoc Health | Maintains: Hold | n/a | $9.32 | - | 1 | Feb 25, 2021 | |
| MDRX Veradigm | Downgrades: Hold | n/a | $9.50 | - | 1 | Apr 22, 2020 | |
| MOH Molina Healthcare | Upgrades: Buy | n/a | $292.16 | - | 5 | Nov 13, 2018 | |
| INCR InterCure | Upgrades: Buy | n/a | $2.03 | - | 1 | Oct 9, 2017 |
Inotiv
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $1.59
Upside: +135.85%
Medpace Holdings
Apr 23, 2024
Upgrades: Buy
Price Target: $340 → $450
Current: $407.24
Upside: +10.50%
Humana
Apr 22, 2024
Maintains: Buy
Price Target: $411 → $381
Current: $373.49
Upside: +2.01%
Elevance Health
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $534.55
Upside: +12.99%
Intuitive Surgical
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $436.24
Upside: -14.04%
Sotera Health Company
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $11.58
Upside: +33.85%
Veeva Systems
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $181.67
Upside: +48.62%
Certara
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $13.64
Upside: +13.64%
West Pharmaceutical Services
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $324.55
Upside: +65.15%
Fortrea Holdings
Jan 4, 2024
Initiates: Buy
Price Target: $44
Current: $23.86
Upside: +84.41%
Cigna
Dec 11, 2023
Upgrades: Buy
Price Target: $335 → $341
Current: $326.27
Upside: +4.51%
UnitedHealth Group
Nov 20, 2023
Maintains: Hold
Price Target: $565 → $503
Current: $494.65
Upside: +1.69%
Stevanato Group
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $18.73
Upside: +54.83%
Centene
Oct 9, 2023
Maintains: Buy
Price Target: $82 → $81
Current: $65.34
Upside: +23.97%
Catalent
Jun 14, 2023
Downgrades: Hold
Price Target: $45 → $44
Current: $56.16
Upside: -21.65%
Charles River Laboratories International
Mar 28, 2023
Maintains: Hold
Price Target: $233 → $203
Current: $203.24
Upside: -0.12%
IQVIA Holdings
Nov 17, 2021
Maintains: Buy
Price Target: n/a
Current: $208.49
Upside: -
ICON PLC
Sep 14, 2021
Maintains: Buy
Price Target: n/a
Current: $316.51
Upside: -
Teladoc Health
Feb 25, 2021
Maintains: Hold
Price Target: n/a
Current: $9.32
Upside: -
Veradigm
Apr 22, 2020
Downgrades: Hold
Price Target: n/a
Current: $9.50
Upside: -
Molina Healthcare
Nov 13, 2018
Upgrades: Buy
Price Target: n/a
Current: $292.16
Upside: -
InterCure
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $2.03
Upside: -